Anxiety sensitivity and modulation of the serotonergic system in patients with PD

Journal of Anxiety Disorders

Volumn 18, Issue 3, 2004, Pages 423-431

  Romano, Pietra ^a   Van Beek, Nicole ^b   Cucchi, Michele ^a   Biffi, Sara ^a   Perna, Giampaolo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Anxiety sensitivity; Carbon dioxide; Cognitive; PD

Indexed keywords

ANTIPANIC AGENT; CITALOPRAM;

ADULT; AGORAPHOBIA; ANXIETY DISORDER; ANXIETY SENSITIVITY; ARTICLE; AVOIDANCE BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; PANIC; PSYCHOMETRY; SEROTONINERGIC SYSTEM; STANDARDIZATION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ANXIETY; CITALOPRAM; FEMALE; HUMANS; MALE; PANIC DISORDER; PSYCHOMETRICS; SENSITIVITY AND SPECIFICITY; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 2342578244     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-6185(02)00295-5     Document Type: Article

References (33)

1. Argyle N., Deltito J., Allerup P., Albus M., Nutziger D., Rasmussen S., Ayuso J.L., Bech P. The Panic-Associated Symptoms Scale: measuring the severity of PD. Acta Psychiatrica Scandinavica. 83:1991;20-26
2. Baer L. Behavior therapy: endogenous serotonin therapy? Journal of Clinical Psychiatry. 57:1996;33-35
3. 2 hyperactivity and clinical symptomatology in patients with PD after one week of treatment with citalopram: an open study. Journal of Clinical Psychopharmacology. 21:2001;262-267
4. Clark D.M., Salkovski P.M., Hackmann A., Middleton H., Anastasiades P., Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of PD. British Journal of Psychiatry. 164:1994;759-769
5. Coplan J.D., Gorman J.M., Klein D.F. Serotonin-related function in PD: a critical overview. Neuropsychopharmacology. 6:1992;189-200
6. Ehlers A. A one-year prospective study of panic attacks: clinical course and factors associated with maintenance. Journal of Abnormal Psychology. 104:1995;164-172
7. Fyer, A. J. (1995). Schedule for Affective Disorders and Schizophrenia lifetime version. Modified for the study of Anxiety Disorders (updated for DSM IV). Anxiety Family Study Unit, Dept. of Therapeutics, New York State Psychiatric Institute.
8. Gorman J.M., Kent J.M., Sullivan G.M., Coplan J.D. Neuroanatomical hypothesis of PD, revised. American Journal of Psychiatry. 157:2000;493-505
9. Imber S.D., Pilkonis P.A., Sotsky S.M., Elkin I., Watkins J.T., Collins J.F., Shea M.T., Leber W.R., Glass D.R. Mode-specific effects among three treatments for depression. Journal of Consult of Clinical Psychology. 58:1990;352-359
10. Kent J.M., Coplan J.D., Gorman J.M. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biological Psychiatry. 44:1998;812-824
11. Leinonen E., Lepola U., Koponen H., Turtonen J., Wade A., Lehto H. Citalopram controls phobic symptoms in patients with panic disorder: randomized, controlled trial. Journal of Psychiatry Neurosci. 25:2000;25-32
12. Lepola U., Leinonen E., Turtoten J. The effect of citalopram in PD and agoraphobia: a pilot study. Nordic Journal of Psychiatry. 48:1994;13-17
13. Lepola U., Wade A.G., Leinonen E., Koponen H.J., Frazer J., Sjodin I., Penttinen I.T., Pedersen T., Letho H.J. A controlled, prospective, one-year trial of citalopram in the treatment of PD. Journal of Clinical Psychiatry. 59:1998;528-534
14. Maller R., Reiss S. Anxiety sensitivity in 1984 and panicks attacks in 1987. Journal of Anxiety Disorders. 6:1992;241-247
15. Marks I.M., Mathews A.M. Brief standard self-rating for phobic patients. Behavior Research and Therapy. 17:1979;263-267
16. Mavissakalian M.R., Perel J.M., Talbott-Green M., Sloan C. Gauging the effectiveness of extended imipramine treatment for PD with agoraphobia. Biological Psychiatry. 43:1998;848-854
17. McNally, R. J. (1994). PD. A critical analysis. New York: Guilford Press.
18. McNally, R. J. (1996). Anxiety sensitivity is distinguishable from trait anxiety. In: R. M. Rapee (Ed.), Current controversies in anxiety disorders research (pp. 214-227). New York: Guilford Press.
19. McNally R.J., Lorenz M. Anxiety sensitivity in agoraphobics. Journal of Behavior Therapy and Experimental Psychiatry. 18:1987;3-11
20. Otto, M. W., Pollack, M. H., Sachs, G. S., Rosenbaum, J. F., & Fava, M. (1991). Anxiety sensitivity as a diathesis for PD: results from a naturalistic, longitudinal study. Paper presented at the 147th Annual Meeting of the American Psychiatric Association, Philadelphia.
21. Perna G., Bertani A., Caldirola D., Smeraldi E., Bellodi L. A comparison of citalopram and paroxetine in the treatment of PD: a randomized, single-blind study. Pharmacopsychiatry. 34:2001;85-90
22. Peterson, R. A., & Reiss, S. (1987). Test manual for the Anxiety Sensitivity Index. Worthington, OH: International Diagnostic System.
23. Peterson, R. A., & Reiss, S. (1992). Anxiety Sensitivity Index manual (2nd ed.). Worthington, OH: International Diagnostic Systems.
24. Rapee R.M., Medoro L. Fear of physical sensations and trait anxiety as mediators of the response to hyperventilation in non clinical subjects. Journal of Abnormal Psychology. 103:1994;693-699
25. Reiss S., Peterson R.A., Gursky D.M., McNally R.J. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behavioral Research and Therapy. 24:1986;1-8
26. Roy-Byrne P.P., Cowley D.S. Search for pathophysiology of PD. Lancet. 352:1998;1646-1647
27. Saviotti F., Grandi M., Savron G., Ermentini R., Bartolucci G., Conti S., Fava G.A. Characterological traits of recovered patients with PD and agoraphobia. Journal of Affective Disorders. 23:1991;113-117
28. Schmidt N.B., Lerew D.R., Jackson R.J. Prospective evaluation of anxiety sensitivity in the pathogenesis of panic: replication and extension. Journal of Abnormal Psychology. 108:1999;532-537
29. Shear M.K., Pilkonis P.S., Cloitre M., Leon A. Cognitive behavioral treatment compared with nonprescriptive treatment of PD. Archives of General Psychiatry. 51:1994;341-395
30. Simons A.D., Garfield S.L., Murphy G.E. The process of change in cognitive therapy and pharmacotherapy for depression. Changes in mood and cognition. Archive of General Psychiatry. 41:1984;45-51
31. Spielberger, C. D., Gorsuch, R., & Lushere, R. (1970). STAI manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
32. Taylor, S. (Ed.). (1999). Anxiety sensitivity. Theory, research, and treatment of fear of anxiety. Mahwah, NJ: Erlbaum.
33. Telch M.J., Lucas J.A., Schmidt N.B., Hanna H.H., Jaimez T.L., Lucas R.A. Group cognitive behavioral treatment of PD. Behaviour Research and Therapy. 31:1993;279-287